Technical Articles

KRAS G12D & CRBN Binding Kit (GDP loaded)

Research progress on direct KRAS G12D inhibitors

2026-03-02

Pancreatic ductal adenocarcinoma, known as the "king of cancers," is notorious for its high malignancy and extremely poor prognosis. The KRAS gene mutation occurs in up to 93% of pancreatic cancer cases, with KRAS G12D being the most common mutation subtype.

View details

Cancer
KRAS G12D & CRBN Binding Kit (GDP loaded)
Pancreatic ductal adenocarcinoma
KRAS gene

Total 1

Go to